 In this study, we observed that sevillomer significantly reduced post-prandial blood sugar and hemoglobin A1C levels in patients with diabetic nephropathy. Additionally, it did not affect lipid profile or high-sensitivity seriactive protein, HSCRP. This article was authored by Sosin-Mohammadi-Kabar, Afshan Shardi, Baaman-Basherdoust, and others.